Parental intention to have daughters receive the human papillomavirus vaccine

CMAJ. Canadian Medical Association Journal

Volumn 177, Issue 12, 2007, Pages 1506-1512

  Ogilvie, Gina S ^a,c   Remple, Valencia P ^a   Marra, Fawziah ^a   McNeil, Shelly A ^b   Naus, Monika ^a,c   Pielak, Karen L ^c   Ehlen, Thomas G ^a   Dobson, Simon R ^a   Money, Deborah M ^a,d   Patrick, David M ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^d PROVINCIAL HEALTH SERVICES AUTHORITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; CANADA; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREVENTION AND CONTROL; SEXUAL BEHAVIOR; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS;

EID: 37049016467     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.071022     Document Type: Article

References (26)

1. Ault KA; Future II Study Group. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 2007;369:1861-8.
2. Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007;369:2161-70.
3. Garnett GP, Kim JJ, French K, et al. Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes. Vaccine 2006;24 Suppl 3: S178-86.
4. Zimet GD, Liddon N, Rosenthal SL, et al. Chapter 24: Psychosocial aspects of vaccine acceptability. Vaccine 2006;24 Suppl 3:S201-9.
5. Erickson LJ, De Wals P, Farand L. An analytical framework for immunization programs in Canada. Vaccine 2005;23:2470-6.
6. Hankins M, French D, Horne R. Statistical guidelines for studies of the theory of reasoned action and the theory of planned behaviour. Psychol Health 2000;15:151-61.
7. Zimet GD, Perkins SM, Sturm LA, et al. Predictors of STI vaccine acceptability among parents and their adolescent children. J Adolesc Health 2005;37:179-86.
8. Zimet GD, Mays RM, Fortenberry JD. Vaccines against sexually transmitted infections: promise and problems of the magic bullets for prevention and control. Sex Transm Dis 2000;27:49-52.
9. Dempsey AF. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 2006;117:1486-93.
10. Colgrove J. The ethics and politics of compulsory HPV vaccination. N Engl J Med 2006;355:2389-91.
11. Marlow LAV, Waller J, Wardle J. Parental attitudes to pre-pubertal HPV vaccination. Vaccine 2007;25:1945-52.
12. Davis K, Dickman ED, Ferris D, et al. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis 2004;8:188-94.
13. Lazcano-Ponce E, Rivera L, Arillo-Santillan E, et al. Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res 2001;32:243-7.
14. Lenselink CH, Gerrits MMJG, Melchers WJG, et al. Parental acceptance of human paillomavirus vaccines. Eur J Obstet Gynecol Reprod Biol DOI: 10.1016/j.ejogrb.2007.02.12. Epub 2007 Mar 16 ahead of print.
15. Kirby D, Laris BA, Rolled L. The impact of sex and HIV education programs in schools and communities on sexual behaviors among young adults. Research Triangle Park (NC): Family Health International, YouthNet Program; 2006. Available: www.fhi.org/NR/rdonlyres/ e2saa3gkcwbr422uoeyiitlrre6pd62cyh63x7rmw7xaibtztb2zvoxpx4sb70xmq7hugymp722f5n/ KirbyFinallongreportv251.pdf (accessed 2007 Oct 12).
16. Monk BJ, Wiley DJ. Will widespread human papillomavirus prophylactic vaccination change sexual practices of adolescent and young adult women in America? Obstet Gynecol 2006;108:420-4.
17. Population by year, by province and territory. Ottawa: Statistics Canada; modified 2006 May 29. Available: www40.statcan.ca/lo1/csto1/demoo2.htm (accessed 2007 Mar 22).
18. Stevenson CG, McArthur MA, Naus M, et al. Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: How are we doing? CMAJ 2001;164:1413-9.
19. Andrew MK, McNeil S, Merry H, et al. Rates of influenza vaccination in older adults and factors associated with vaccine use: a secondary analysis of the Canadian Study of Health and Aging. BMC Public Health 2004;4:36.
20. Pollack A, Saul S. Merck to halt lobbying for vaccine for girls. New York Times 2007 Feb 21. Available: www.nytimes.com/2007/02/21/business/ 21merck.html (accessed 2007 Oct 12).
21. Noakes K, Yarwood J, Salisbury D. Parental response to the introduction of a vaccine against human papilloma virus. Hum Vaccin 2006;2:243-8.
22. Voigt LF, Koepsell TD, Daling JR. Characteristics of telephone survey respondents according to willingness to participate. Am J Epidemiol 2003;157:66-73.
23. Brabin L, Roberts SA, Farzaneh F, et al. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine 2006;24:3087-94.
24. Flaherty JM. A better Canada. In: The budget plan 2007. Aspire to a strong, safer, better Canada. Ottawa: Department of Finance Canada; 2007. Available: www.budget.gc.ca/2007/bp/bpc3e.html (accessed 2007 Oct 12).
25. Human papilloma virus immunization program. Toronto: Government of Ontario, Ministry of Health and Long-Term Care; 2007 Aug 2. Available: www.health.gov.on.ca/english/media/news_releases/archives/nr_07/aug/bg_20070802. html (accessed 2007 Oct 12).
26. HPV immunization launched [news release]. Halifax: Government of Nova Scotia, Health Promotion and Protection; 2007 June 20. Available: www.gov.ns.ca/news/details.asp?id=20070620002 (accessed 2007 Oct 12).